Multicenter, Open-label, Single-arm Study to Evaluate Hormone and Lipid Levels in Male Subjects With Partial-onset Seizures After a Switch of Treatment From Carbamazepine as Adjunctive Treatment to Levetiracetam to Lacosamide as Adjunctive Treatment to Levetiracetam

Trial Profile

Multicenter, Open-label, Single-arm Study to Evaluate Hormone and Lipid Levels in Male Subjects With Partial-onset Seizures After a Switch of Treatment From Carbamazepine as Adjunctive Treatment to Levetiracetam to Lacosamide as Adjunctive Treatment to Levetiracetam

Discontinued
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2014

At a glance

  • Drugs Lacosamide (Primary) ; Levetiracetam
  • Indications Partial epilepsies
  • Focus Pharmacodynamics
  • Acronyms VICTOR
  • Sponsors UCB
  • Most Recent Events

    • 26 Nov 2012 Planned end date changed from 1 Apr 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
    • 19 Jun 2012 Additional trial centres identified as reported by ClinicalTrials.gov.
    • 14 May 2012 Additional trial location (Austria) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top